[Targeting for drug delivery and imaging: an overview of the state of the art in cancer].
The concept of drug targeting has resulted in a considerable variety of tools within nanotechnology, whose potentials in the special field of cancer are very interesting. There is a strong link between the structure and the surface of the vector on the one hand, and the biological target thus accessible on the other hand, as illustrated a number of typical examples. Parallel developments were made in the fields of therapy and diagnosis, stage by stage. The challenges now live in the combination of approaches widely reported under the terminology of "theranostics".
Université Paris-Sud, Chatenay-Malabry, France. catherine.dubernet@u-psud.fr
Catherine
C
Dubernet
D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D050997:Nanomedicine / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*